obesity glp-1 news today Do people with need to take a for the rest of their life? Weight loss with GLP-1 medicines

A network meta-analysis comparing the effects of glucose-lowering therapy on body weight and blood pressure indicates that the greatest efficacy for reducing body weight is seen with subcutaneous semaglutide followed by the other GLP-1 RA and SGLT2i, and the greatest reduction in blood pressure is seen with the SGLT2i and GLP-1 RA classes [224]

Abdominal distension was the most common symptom at a prevalence of 92%, while postprandial fullness, diarrhea, abdominal pain, and constipation were reported in 55-73% of cases

Fourth, coordinate-based meta-analyses are insensitive to non-significant results

Abdominal pain, discomfort, or bloating may occur in approximately ten percent of patients receiving Semaglutide / Cyanocobalamin Injection

This report by The Canadian Press was first published March 3, 2026